308 related articles for article (PubMed ID: 30213639)
1. Development and clinical consequences of white matter lesions in Fabry disease: a systematic review.
Körver S; Vergouwe M; Hollak CEM; van Schaik IN; Langeveld M
Mol Genet Metab; 2018 Nov; 125(3):205-216. PubMed ID: 30213639
[TBL] [Abstract][Full Text] [Related]
2. Enzyme replacement therapy stabilized white matter lesion progression in Fabry disease.
Fellgiebel A; Gartenschläger M; Wildberger K; Scheurich A; Desnick RJ; Sims K
Cerebrovasc Dis; 2014; 38(6):448-56. PubMed ID: 25502511
[TBL] [Abstract][Full Text] [Related]
3. Determinants of cerebral radiological progression in Fabry disease.
Körver S; Longo MGF; Lima MR; Hollak CEM; El Sayed M; van Schaik IN; Vedolin L; Dijkgraaf MGW; Langeveld M
J Neurol Neurosurg Psychiatry; 2020 Jul; 91(7):756-763. PubMed ID: 32317398
[TBL] [Abstract][Full Text] [Related]
4. Brain MRI findings in children and adolescents with Fabry disease.
Marchesoni C; Cisneros E; Pfister P; Yáñez P; Rollan C; Romero C; Kisinovsky I; Rattagan L; León Cejas L; Pardal A; Sevlever G; Reisin R
J Neurol Sci; 2018 Dec; 395():131-134. PubMed ID: 30316069
[TBL] [Abstract][Full Text] [Related]
5. Neurological complications of Anderson-Fabry disease.
Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Arnao V; Licata G; Pinto A
Curr Pharm Des; 2013; 19(33):6014-30. PubMed ID: 23448452
[TBL] [Abstract][Full Text] [Related]
6. [Pathophysiological aspects of brain structural disturbances in patients with Fabry disease: literature review].
Nill M; Müller MJ; Beck M; Stoeter P; Fellgiebel A
Fortschr Neurol Psychiatr; 2006 Dec; 74(12):687-95. PubMed ID: 17167727
[TBL] [Abstract][Full Text] [Related]
7. Pattern of microstructural brain tissue alterations in Fabry disease: a diffusion-tensor imaging study.
Fellgiebel A; Mazanek M; Whybra C; Beck M; Hartung R; Müller KM; Scheurich A; Dellani PR; Stoeter P; Müller MJ
J Neurol; 2006 Jun; 253(6):780-7. PubMed ID: 16511647
[TBL] [Abstract][Full Text] [Related]
8. Determinants of white matter hyperintensity burden in patients with Fabry disease.
Rost NS; Cloonan L; Kanakis AS; Fitzpatrick KM; Azzariti DR; Clarke V; Lourenco CM; Germain DP; Politei JM; Homola GA; Sommer C; Üçeyler N; Sims KB
Neurology; 2016 May; 86(20):1880-6. PubMed ID: 27164662
[TBL] [Abstract][Full Text] [Related]
9. Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis.
Cocozza S; Olivo G; Riccio E; Russo C; Pontillo G; Ugga L; Migliaccio S; de Rosa D; Feriozzi S; Veroux M; Battaglia Y; Concolino D; Pieruzzi F; Tuttolomondo A; Caronia A; Russo CV; Lanzillo R; Brescia Morra V; Imbriaco M; Brunetti A; Tedeschi E; Pisani A
Neuroradiology; 2017 Jun; 59(6):563-570. PubMed ID: 28386689
[TBL] [Abstract][Full Text] [Related]
10. White matter lesion severity in male and female patients with Fabry disease.
Fellgiebel A; Müller MJ; Mazanek M; Baron K; Beck M; Stoeter P
Neurology; 2005 Aug; 65(4):600-2. PubMed ID: 16116124
[TBL] [Abstract][Full Text] [Related]
11. Stroke and Fabry disease.
Viana-Baptista M
J Neurol; 2012 Jun; 259(6):1019-28. PubMed ID: 22037950
[TBL] [Abstract][Full Text] [Related]
12. Reversibility of White Matter Hyperintensity by Revascularization Surgery in Moyamoya Disease.
Komatsu K; Mikami T; Noshiro S; Miyata K; Wanibuchi M; Mikuni N
J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1495-502. PubMed ID: 27038979
[TBL] [Abstract][Full Text] [Related]
13. Neuroradiological differentiation of white matter lesions in patients with multiple sclerosis and Fabry disease.
Rath J; Foesleitner O; Haider L; Bickel H; Leutmezer F; Polanec S; Arnoldner MA; Sunder-Plassmann G; Prayer D; Berger T; Rommer P; Kasprian G
Orphanet J Rare Dis; 2022 Feb; 17(1):37. PubMed ID: 35123534
[TBL] [Abstract][Full Text] [Related]
14. Voxel based analyses of diffusion tensor imaging in Fabry disease.
Albrecht J; Dellani PR; Müller MJ; Schermuly I; Beck M; Stoeter P; Gerhard A; Fellgiebel A
J Neurol Neurosurg Psychiatry; 2007 Sep; 78(9):964-9. PubMed ID: 17449543
[TBL] [Abstract][Full Text] [Related]
15. MRI-visible perivascular spaces as an imaging biomarker in Fabry disease.
Lyndon D; Davagnanam I; Wilson D; Jichi F; Merwick A; Bolsover F; Jager HR; Cipolotti L; Wheeler-Kingshott C; Hughes D; Murphy E; Lachmann R; Werring DJ
J Neurol; 2021 Mar; 268(3):872-878. PubMed ID: 33078310
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and Risk Factors of White Matter Lesions in Tibetan Patients Without Acute Stroke.
Jin H; Ding Z; Lian S; Zhao Y; He S; Zhou L; Zhuoga C; Wang H; Xu J; Du A; Yan G; Sun Y
Stroke; 2020 Jan; 51(1):149-153. PubMed ID: 31679502
[TBL] [Abstract][Full Text] [Related]
17. White Matter Lesions Predict Recurrent Vascular Events in Patients with Transient Ischemic Attacks.
Ren XM; Qiu SW; Liu RY; Wu WB; Xu Y; Zhou H
Chin Med J (Engl); 2018 Jan; 131(2):130-136. PubMed ID: 29336359
[TBL] [Abstract][Full Text] [Related]
18. De novo Diagnosis of Fabry Disease among Italian Adults with Acute Ischemic Stroke or Transient Ischemic Attack.
Romani I; Borsini W; Nencini P; Morrone A; Ferri L; Frusconi S; Donadio VA; Liguori R; Donati MA; Falconi S; Pracucci G; Inzitari D
J Stroke Cerebrovasc Dis; 2015 Nov; 24(11):2588-95. PubMed ID: 26298600
[TBL] [Abstract][Full Text] [Related]
19. Brain magnetic resonance imaging findings fail to suspect Fabry disease in young patients with an acute cerebrovascular event.
Fazekas F; Enzinger C; Schmidt R; Grittner U; Giese AK; Hennerici MG; Huber R; Jungehulsing GJ; Kaps M; Kessler C; Martus P; Putaala J; Ropele S; Tanislav C; Tatlisumak T; Thijs V; von Sarnowski B; Norrving B; Rolfs A;
Stroke; 2015 Jun; 46(6):1548-53. PubMed ID: 25899239
[TBL] [Abstract][Full Text] [Related]
20. Brain MRI findings in patients with Fabry disease.
Reisin RC; Romero C; Marchesoni C; Nápoli G; Kisinovsky I; Cáceres G; Sevlever G
J Neurol Sci; 2011 Jun; 305(1-2):41-4. PubMed ID: 21463870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
